Predicting response to phenothiazines: the right drug for the right patient.

Suppr

超能文献

作者信息

Galbrecht C R, Klett C J

出版信息

J Nerv Ment Dis. 1968 Aug;147(2):173-83. doi: 10.1097/00005053-196808000-00009.

DOI:10.1097/00005053-196808000-00009

PMID:5677325

Abstract

摘要

相似文献

Predicting response to phenothiazines: the right drug for the right patient.

J Nerv Ment Dis. 1968 Aug;147(2):173-83. doi: 10.1097/00005053-196808000-00009.

Intramuscular long-acting fluphenazine in the treatment of schizophrenia.

Acta Psychiatr Scand. 1970;46(3):225-37. doi: 10.1111/j.1600-0447.1970.tb02115.x.

Triiodothyronine and phenothiazines in schizophrenia.

Dis Nerv Syst. 1969 Jul;30(7):487-9.

II. Major tranquilizers.

South Med J. 1971 Apr;64(4):403-10. doi: 10.1097/00007611-197104000-00005.

Depression following fluphenazine treatment.

Br Med J. 1969 Sep 27;3(5673):780. doi: 10.1136/bmj.3.5673.780-a.

Blood levels of neuroleptics: state of the art.

J Clin Psychiatry. 1985 May;46(5 Pt 2):22-8.

Drug treatment in newly admitted schizophrenic patients.

Arch Gen Psychiatry. 1971 Nov;25(5):404-9. doi: 10.1001/archpsyc.1971.01750170020004.

Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.

J Am Geriatr Soc. 1973 Jun;21(6):241-8. doi: 10.1111/j.1532-5415.1973.tb01683.x.

Dopamine antagonism by thioridazine in schizophrenia.

Biol Psychiatry. 1975 Feb;10(1):53-7.

Letter: Possible effects of combining phenothiazines.

Am J Psychiatry. 1974 Dec;131(12):1408-9.

引用本文的文献

Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy.

Oncologist. 2019 Jul;24(7):e432-e440. doi: 10.1634/theoncologist.2019-0054. Epub 2019 Apr 2.

The Black Book of Psychotropic Dosing and Monitoring.

Psychopharmacol Bull. 2018 Jan 15;48(1):64-153.

Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.

Cochrane Database Syst Rev. 2014 Aug 3;2014(8):CD009230. doi: 10.1002/14651858.CD009230.pub2.

Chlorpromazine versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2014 Jan 6;2014(1):CD000284. doi: 10.1002/14651858.CD000284.pub3.

Thioridazine for schizophrenia.

Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001944. doi: 10.1002/14651858.CD001944.pub2.

Neuroleptic dysphoria: towards a new synthesis.

Psychopharmacology (Berl). 2004 Jan;171(2):121-32. doi: 10.1007/s00213-003-1648-y. Epub 2003 Nov 27.

The treatment-resistant patient and the need to stay crazy.

Psychiatr Q. 1984 Spring;56(1):75-82. doi: 10.1007/BF01324635.

Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Drugs. 1972;4(5):321-60. doi: 10.2165/00003495-197204050-00001.

Efficacy of loxapine in the treatment of paranoid schizophrenia.

Psychopharmacology (Berl). 1977 Jan 31;51(2):107-15. doi: 10.1007/BF00431725.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Predicting response to phenothiazines: the right drug for the right patient.

J Nerv Ment Dis. 1968 Aug;147(2):173-83. doi: 10.1097/00005053-196808000-00009.

Intramuscular long-acting fluphenazine in the treatment of schizophrenia.

Acta Psychiatr Scand. 1970;46(3):225-37. doi: 10.1111/j.1600-0447.1970.tb02115.x.

Triiodothyronine and phenothiazines in schizophrenia.

Dis Nerv Syst. 1969 Jul;30(7):487-9.

II. Major tranquilizers.

South Med J. 1971 Apr;64(4):403-10. doi: 10.1097/00007611-197104000-00005.

Depression following fluphenazine treatment.

Br Med J. 1969 Sep 27;3(5673):780. doi: 10.1136/bmj.3.5673.780-a.

Blood levels of neuroleptics: state of the art.

J Clin Psychiatry. 1985 May;46(5 Pt 2):22-8.

Drug treatment in newly admitted schizophrenic patients.

Arch Gen Psychiatry. 1971 Nov;25(5):404-9. doi: 10.1001/archpsyc.1971.01750170020004.

Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.

J Am Geriatr Soc. 1973 Jun;21(6):241-8. doi: 10.1111/j.1532-5415.1973.tb01683.x.

Dopamine antagonism by thioridazine in schizophrenia.

Biol Psychiatry. 1975 Feb;10(1):53-7.

Letter: Possible effects of combining phenothiazines.

Am J Psychiatry. 1974 Dec;131(12):1408-9.

引用本文的文献

Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy.

Oncologist. 2019 Jul;24(7):e432-e440. doi: 10.1634/theoncologist.2019-0054. Epub 2019 Apr 2.

The Black Book of Psychotropic Dosing and Monitoring.

Psychopharmacol Bull. 2018 Jan 15;48(1):64-153.

Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.

Cochrane Database Syst Rev. 2014 Aug 3;2014(8):CD009230. doi: 10.1002/14651858.CD009230.pub2.

Chlorpromazine versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2014 Jan 6;2014(1):CD000284. doi: 10.1002/14651858.CD000284.pub3.

Thioridazine for schizophrenia.

Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001944. doi: 10.1002/14651858.CD001944.pub2.

Neuroleptic dysphoria: towards a new synthesis.

Psychopharmacology (Berl). 2004 Jan;171(2):121-32. doi: 10.1007/s00213-003-1648-y. Epub 2003 Nov 27.

The treatment-resistant patient and the need to stay crazy.

Psychiatr Q. 1984 Spring;56(1):75-82. doi: 10.1007/BF01324635.

Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Drugs. 1972;4(5):321-60. doi: 10.2165/00003495-197204050-00001.

Efficacy of loxapine in the treatment of paranoid schizophrenia.

Psychopharmacology (Berl). 1977 Jan 31;51(2):107-15. doi: 10.1007/BF00431725.